FMP
Generation Bio Co.
GBIO
NASDAQ
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
3.01 USD
0.02 (0.664%)
About
ceo
Dr. Cameron Geoffrey McDonough M.D.
sector
Healthcare
industry
Biotechnology
website
https://generationbio.com
exchange
NASDAQ
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
CIK
0001733294
ISIN
US37148K1007
CUSIP
37148K100
Address
301 Binney Street
Phone
617 655 7500
Country
US
Employee
174
IPO Date
Jun 12, 2020
Summary
CIK
0001733294
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
37148K100
ISIN
US37148K1007
Country
US
Price
3.01
Beta
2.79
Volume Avg.
241.15k
Market Cap
200.1M
Shares
-
52-Week
0.86-6.98
DCF
-0.24
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.54
P/B
-
Website
https://generationbio.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest GBIO News
It looks like there's no news available.
